Eastman Kodak Company (KODK) Q4 2024 earnings summary

Executive summary

• Executed long-term strategy by investing in innovation, operational efficiency, and exiting unprofitable businesses, resulting in improved gross profit margins despite revenue declines.

• Advanced Materials & Chemicals (AMC) segment delivered revenue and profit growth, with investments in capacity, technology, and a new cGMP pharma facility scheduled for 2025.

• Print segment experienced revenue and profit declines, partially offset by AMC gains, and completed a successful tariff petition supporting U.S. manufacturing.

• Board approved termination of the Kodak Retirement Income Plan, with asset reversion expected to reduce long-term debt.

• Year-end cash balance was $201M, down $54M, reflecting capital expenditures for growth and technology investments.

Financial highlights

• Q4 2024 revenue was $266M, down 3% year-over-year; full year revenue was $1.043B, down 7%.

• Q4 gross profit margin improved to 19% from 17% year-over-year; full year gross margin remained flat at 19%.

• Q4 net income was $26M, up from $5M in Q4 2023; full year net income was $102M, up 36% from 2023.

• Q4 operational EBITDA was $9M, up from $2M; full year operational EBITDA was $26M, down from $45M.

• Adjusted net income for Q4 was $27M (up 125%); for the full year, $87M (down 12%).

Outlook and guidance

• Focus remains on smart revenue, innovation, operational efficiency, and automation to slow revenue decline and drive profitability.

• Continued investment in AMC, digital print technologies, and a new cGMP pharma facility expected to begin production in 2025.

• Proceeds from pension plan reversion expected to reduce long-term debt and support growth initiatives.